publication venue for
- Multivalent cytomegalovirus glycoprotein B nucleoside modified mRNA vaccines did not demonstrate a greater antibody breadth.. 9. 2024
- Conjugation of HIV-1 envelope to hepatitis B surface antigen alters vaccine responses in rhesus macaques.. 8. 2023
- Vaccination with a replication-defective cytomegalovirus vaccine elicits a glycoprotein B-specific monoclonal antibody repertoire distinct from natural infection.. 8. 2023
- CD4 T cell epitope abundance in ferritin core potentiates responses to hemagglutinin nanoparticle vaccines.. 7. 2022
- Heat-inactivated modified vaccinia virus Ankara boosts Th1 cellular and humoral immunity as a vaccine adjuvant.. 7. 2022
- Leveraging antigenic seniority for maternal vaccination to prevent mother-to-child transmission of HIV-1.. 7. 2022
- Interplay of diverse adjuvants and nanoparticle presentation of native-like HIV-1 envelope trimers.. 6. 2021
- Access to and equitable distribution of COVID-19 vaccine in low-income countries.. 6. 2021
- Immunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles.. 6. 2021
- Heterologous viral protein interactions within licensed seasonal influenza virus vaccines.. 5. 2020
- An autophagy-inducing and TLR-2 activating BCG vaccine induces a robust protection against tuberculosis in mice.. 4. 2019
- A new era in cytomegalovirus vaccinology: considerations for rational design of next-generation vaccines to prevent congenital cytomegalovirus infection. 2018